Yun (Kenneth) Kang

home / authors / yun-kenneth-kang

Yun (Kenneth) Kang is director of Process Development at Patheon Biologics.

Articles

Development of Purification for Challenging Fc-Fusion Proteins

Development of Purification for Challenging Fc-Fusion Proteins

Yun (Kenneth) Kang;Jay Jicao Kang;Richard Ding;Guodong Chen;Evan Shave;Ijeoma Cynthia Ikechukwu

October 1st 2017

This study outlines methods for an alternative protein-polishing process for challenging proteins.

Development of an Alternative Monoclonal Antibody Polishing Step

Josaih Adaelu;Stanley Ng;Dale Ludwig;Yun (Kenneth) Kang;Paul Balderes;Kris Persaud;Bo Qi

MAb polishing using salt tolerant interaction membrane chromatography.

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

Published: December 9th 2024 | Updated: December 21st 2024

Recap Key Industry Trends for Viral Clearance and NGS

Shining Pro - Stock.Adobe.com

Published: December 7th 2024 | Updated: December 21st 2024

Enhancing Quality Through Training

Published: July 20th 2020 | Updated: December 21st 2024

Contact BioPharm International Editors

Published: July 19th 2020 | Updated: December 21st 2024

Editorial Information: BioPharm International Submission Guidelines and Editorial Calendars

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.